Evidence map›Paper›PMID 40026564›Full record

ArticleThe journal of liquid biopsy2024

Clinical Impact of Multi-omics profiling of extracellular vesicles in cancer Liquid Biopsy.

Mrunal Kulkarni, Rishav Kar, Srestha Ghosh, Swarup Sonar, Divya Mirgh, Indra Sivakumar, Abhijit Nayak, Raman Muthusamy

Abstract read
In one paragraph

Article in The journal of liquid biopsy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Molecular Mechanisms and Immune Regulation in Prostate Cancer: A Review.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  14. Article
  15. The Landscape of Exosomes Biogenesis to Clinical Applications.International journal of nanomedicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mrunal KulkarniDepartment of Pharmacy, BITS Pilani, Rajasthan, 333031, India.
Rishav KarSchool of Biological Sciences, Ramakrishna Mission Vivekananda Educational and Research Institute (RKMVERI), Kolkata, 700026, India.
Srestha GhoshDepartment of Microbiology, Lady Brabourne College, Kolkata, West Bengal, 700017, India.
Swarup SonarGenpact, Badshahpur, Sector 69, Gurugram, Haryana, 12210, India.
Divya MirghDepartment of Infectious Diseases, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
Indra SivakumarDept of Medical Microbiology, Saveetha Medical College and Hospitals, SIMATS, Chennai, 602105, Tamil Nadu, India.
Abhijit NayakInstitute of Dental Sciences, SOA University, Bhubaneswar, Odisha, 751003, India.
Raman MuthusamyCenter for Global Health Research, Saveetha Medical College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) are the cell's secreted component. It is majorly classified into microvesicles, apoptotic bodies, and exosomes. Exosomes play a significant role in cancer development and progression. Its molecular signature (DNA, RNA, Proteins, lipids) has more priority in cancer profiling current decade. In cancer prevention, the most challenging part is early detection. EVs-based cancer screening develops a promising platform. Multi-Omics exosomes profiling-based liquid biopsy support early cancer detection more efficient way. This approach provides detailed molecular expression data (it may be inner cargos or surface express molecules). This article highlited multi-omic exosome profiling-based exosome theranostics applications in cancer, technical challenges, and improvisation for future improvement.

Indexed as

BiomarkersCancerExosomesMulti-omics

Identifiers

PMID40026564
PMCPMC11863700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.